Literature DB >> 17538882

Glucocorticoid-induced tumor necrosis factor receptor family-related protein triggering enhances HIV-specific CD4+ T cell cytokine secretion and protects HIV-specific CD4+ T cells from apoptosis.

Timothy P Lahey1, Suzanne D Loisel, Wendy Wieland-Alter.   

Abstract

Human immunodeficiency virus (HIV)-specific CD4(+) T cell cytokine secretion is characteristically weak during HIV infection, in part because HIV-specific CD4(+) T cells undergo massive apoptotic deletion. Glucocorticoid-induced tumor necrosis factor (TNF) receptor family-related (GITR) protein triggering enhances murine antigen-specific T cell cytokine secretion by protecting T cells from apoptosis. Therefore, we investigated the impact of GITR triggering on HIV-specific CD4(+) T cell cytokine secretion and on apoptosis of HIV-specific CD4(+) T cells. In HIV-infected subjects, CD4(+) T cell surface expression of GITR was greater than that in uninfected control subjects, and phytohemagglutinin induction of additional GITR expression was impaired. However, antibody triggering of GITR significantly increased HIV-specific CD4(+) T cell expression of TNF- alpha and interferon (IFN)- gamma . The percentage increase in HIV-specific CD4(+) T cell expression of TNF- alpha correlated directly with the absolute peripheral CD4(+) T cell count. Furthermore, GITR triggering reduced the expression of intracellular activated caspase-3 in HIV-specific CD4(+) T cells. Taken together, these data suggest that, despite abnormal GITR expression during HIV infection, GITR triggering enhances HIV-specific CD4(+) T cell cytokine expression and protects HIV-specific CD4(+) T cells from apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17538882      PMCID: PMC2872147          DOI: 10.1086/518613

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.

Authors:  Nilufer Seth; Daniel Kaufmann; Timothy Lahey; Eric S Rosenberg; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

2.  HIV gp41-induced apoptosis is mediated by caspase-3-dependent mitochondrial depolarization, which is inhibited by HIV protease inhibitor nelfinavir.

Authors:  Himanshu Garg; Robert Blumenthal
Journal:  J Leukoc Biol       Date:  2005-12-05       Impact factor: 4.962

3.  Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

Authors:  Geoffrey W Stone; Suzanne Barzee; Victoria Snarsky; Kristin Kee; Celsa A Spina; Xiao-Fang Yu; Richard S Kornbluth
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  FOXP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients.

Authors:  Pol André Apoil; Bénédicte Puissant; Francis Roubinet; Michel Abbal; Patrice Massip; Antoine Blancher
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

5.  Spontaneous programmed cell death of peripheral blood mononuclear cells from HIV-infected persons is decreased with interleukin-15.

Authors:  K H Chang; J M Kim; H Y Kim; Y G Song; Y H Choi; Y S Park; J H Cho; S K Hong
Journal:  Yonsei Med J       Date:  2000-02       Impact factor: 2.759

6.  Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137L.

Authors:  Jacob Bukczynski; Tao Wen; Chao Wang; Natasha Christie; Jean-Pierre Routy; Mohamed-Rachid Boulassel; Colin M Kovacs; Kelly S Macdonald; Mario Ostrowski; Rafick-Pierre Sekaly; Nicole F Bernard; Tania H Watts
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

7.  In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology.

Authors:  Susmit Suvas; Bumseok Kim; Pranita P Sarangi; Masahide Tone; Herman Waldmann; Barry T Rouse
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 8.  Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy.

Authors:  M L Gougeon; L Montagnier
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

9.  OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition.

Authors:  Qigui Yu; Feng Yun Yue; Xiao X Gu; Herbert Schwartz; Colin M Kovacs; Mario A Ostrowski
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

10.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

Authors:  Constantinos Petrovas; Joseph P Casazza; Jason M Brenchley; David A Price; Emma Gostick; William C Adams; Melissa L Precopio; Timothy Schacker; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

View more
  4 in total

1.  Anti-GITR therapy promotes immunity against malignant glioma in a murine model.

Authors:  Jason Miska; Aida Rashidi; Alan L Chang; Megan E Muroski; Yu Han; Lingjiao Zhang; Maciej S Lesniak
Journal:  Cancer Immunol Immunother       Date:  2016-10-12       Impact factor: 6.968

Review 2.  So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Authors:  Adam J Kleinman; Ivona Pandrea; Cristian Apetrei
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

Review 3.  Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.

Authors:  Theresa Placke; Hans-Georg Kopp; Helmut Rainer Salih
Journal:  Clin Dev Immunol       Date:  2010-09-26

Review 4.  Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.

Authors:  Ross Cromarty; Derseree Archary
Journal:  AIDS Res Treat       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.